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Electroanatomic Substrate and
Ablation Outcome for Suspected Epicardial
Ventricular Tachycardia in Left Ventricular
Nonischemic Cardiomyopathy
Oscar Cano, MD,*† Mathew Hutchinson, MD,* David Lin, MD,* Fermin Garcia, MD,*
Erica Zado, PA-C,* Rupa Bala, MD,* Michael Riley, MD, PHD,* Joshua Cooper, MD,*
Sanjay Dixit, MD,* Edward Gerstenfeld, MD,* David Callans, MD,* Francis E. Marchlinski, MD*
Philadelphia, Pennsylvania; and Barcelona, Spain
Objectives The aim of the study was to define the epicardial substrate and ablation outcome in patients with left ventricular
nonischemic cardiomyopathy (NICM) and suspected epicardial ventricular tachycardia (VT).
Background Ventricular tachycardia in NICM often originates from the epicardium.
Methods Twenty-two patients with NICM underwent detailed endocardial and epicardial bipolar voltage maps and VT abla-
tion for suspected epicardial VT. Eight patients with normal hearts and idiopathic VT served to define normal epi-
cardial electrograms. Low-voltage regions were also assessed for wide (80 ms), split, or late electrograms.
Results Normal epicardial bipolar voltage was identified as 1.0 mV on the basis of the reference population. Confluent
low-voltage areas were present in 18 epicardial (82%) and 12 endocardial (54%) maps and were typically over
basal lateral LV. In the 18 patients with epicardial VT on the basis of activation/pacemapping, the mean epicar-
dial area was greater than the endocardial low-voltage area (55.3  33.5 cm2 vs. 22.9  32.4 cm2, p  0.01).
Epicardial low-voltage areas showed 49.7% wide (80 ms), split, and/or late electrograms rarely seen in the
reference patients (2.3%). During follow-up of 18  7 months, ablation resulted in VT elimination in 15 of 21
patients (71%) including 14 of 18 patients (78%) with epicardial VT.
Conclusions In patients with NICM and VT of epicardial origin, the substrate is characterized by areas of basal LV epicardial
 endocardial bipolar low voltage. The electrograms in these areas are not only small (1.0 mV) but wide (80
ms), split, and/or late, and help identify the substrate targeted for successful ablation. (J Am Coll Cardiol
2009;54:799–808) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.05.032s
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nndocardial ventricular tachycardia (VT) ablation in pa-
ients with left ventricular (LV) nonischemic dilated cardio-
yopathy (NICM) is associated with lower success rates
hen compared with VT ablation in patients with ischemic
ardiomyopathy (1–4). This difference in efficacy might be
ue to the presence of epicardial substrate and VT circuits in
ICM that cannot be successfully ablated from the endo-
ardium (1–4).
rom the *Electrophysiology Section, Cardiovascular Division, Department of
edicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylva-
ia; and the †Universitat Autònoma de Barcelona, Barcelona, Spain. Drs. Hutchin-
on, Lin, Garcia, Bala, Riley, Cooper, Dixit, Gerstenfeld, Callans, and Marchlinski
ave all participated in clinical research protocols on endocardial ventricular tachy-
ardia ablation in patients with coronary artery disease sponsored by Biosense Webster
ut unrelated to the paper’s content.V
Manuscript received February 9, 2009; revised manuscript received April 27, 2009,
ccepted May 5, 2009.The relevance and characteristics of the epicardial sub-
trate have been suggested in small series of patients but have
ot been clearly defined (3,4). The objective of this study
as to describe and compare the endocardial and epicardial
See page 809
ubstrate and to evaluate the outcome with VT ablation in
consecutive series of patients with NICM and VT
uspected of being of epicardial origin.
ethods
tudy population. Detailed electroanatomic data were ob-
ained from 22 consecutive patients with an NICM diag-
osis who underwent epicardial sinus rhythm mapping and
T ablation in our institution over a 5-year period from
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This dataset was selected to per-
mit long-term follow-up out-
come data for at least 1 year in all
surviving patients. The decision
for an epicardial approach was
made on the basis of the charac-
teristics of the VT in the surface
12-lead electrocardiogram (ECG)
suggesting an epicardial origin
(n  2 patients) and/or failure of
prior endocardial ablation (n 
20 patients) (5,6). In all 22 pa-
tients (19 men, age 56  13
years, LV ejection fraction: 30 
13%) the diagnosis of NICM
as established by the absence of significant (75% steno-
is) coronary artery disease, prior myocardial infarction, or
rimary valvular abnormalities. Other causes of dilated
ardiomyopathy were also excluded, including right ventric-
lar dysplasia/cardiomyopathy, cardiac sarcoidosis, and al-
oholic cardiomyopathy. All study patients had a previous
istory of spontaneous sustained monomorphic VT docu-
ented either by surface ECG or stored intracardiac elec-
rograms from an implantable cardioverter-defibrillator
ICD). An additional group of 8 patients with no evidence
f structural heart disease and idiopathic VT were also
tudied to establish normal reference values for epicardial
lectrograms. All procedures were performed following the
nstitutional guidelines of the University of Pennsylvania
ealth System, and all patients provided written informed
onsent.
inus rhythm electroanatomical mapping. Electroana-
omical mapping of the endocardium and the epicardium
uring the baseline rhythm was performed at the same
rocedure with the CARTO system (Biosense Webster
nc., Diamond Bar, California) as previously described
2–4,7). A 4-mm solid distal-tip electrode and 2-mm ring
lectrode ablation catheter (NaviStar) or a 3.5-mm distal tip
rrigated catheter (Navistar Thermocool, Biosense Webster
nc.) was used as the mapping catheter. Bipolar signals were
ltered at 30 to 400 Hz and displayed at 200 mm/s. A
etailed assessment of individual electrogram characteristics
as also made offline. A retrograde transaortic approach was
sed to access the endocardial LV in all cases except 1 in
hich a transseptal puncture was necessary for LV endo-
ardial access via the mitral orifice. Access to the pericardial
pace and epicardium was obtained with the technique
escribed by Sosa et al. (8). Briefly, under general anesthe-
ia, a Tuohy needle was introduced via a subxiphoid
pproach to gain access for sheath and mapping/ablation
atheter placement.
eference values for defining voltage abnormality with
lectroanatomical mapping. The reference value for de-
ning abnormal electrogram voltage in the LV endocardium
Abbreviations
and Acronyms
AV  atrioventricular
ECG  electrocardiogram
ICD  implantable
cardioverter-defibrillator
LP  late potential
LV  left ventricle/
ventricular
NICM  nonischemic
cardiomyopathy
RF  radiofrequency
VT  ventricular
tachycardiaas previously established at 1.5 mV with the CARTO
v
vystem (7). To define normal epicardial signal amplitude
nd characteristics, we studied 8 additional patients (3 men,
ean age 47 16 years) with structurally normal hearts and
diopathic VT or frequent ventricular premature depolariza-
ions who underwent epicardial mapping for suspected
picardial VT (Table 1). Detailed electroanatomical map-
ing of the epicardium was performed during sinus rhythm
n all 8 patients with a 4-mm solid distal-tip electrode and
-mm ring electrode ablation catheter (NaviStar). A mean
f 212  102 epicardial points was recorded/patient. Low-
oltage areas have been previously described around the
trioventricular (AV) groove as well as surrounding the large
oronary vessels as a result of the normal distribution of fat
issue on the epicardium (9,10). To attempt to delineate the
nfluence of fat and coronary anatomy and further define
ormal epicardial electrogram characteristics, we reassessed
lectrogram characteristics both before and after excluding
he region within 1.5 cm of large epicardial coronary vessels
efined by coronary angiography and those areas outside
hat margin (Fig. 1). In 3 of the 8 reference patients with
diopathic VT focal VT/ventricular premature depolariza-
ion origin was identified at the epicardial LV base in 2
atients and at the epicardial LV apex in 1 patient. No
lectrogram abnormalities were recorded in sinus rhythm
rom the sites of origin. In the 5 remaining patients an
picardial origin for VT was not identified despite the
etailed mapping, and VTs were mapped and ablated from
he aortic sinus of Valsalva (n  3), the coronary sinus (n 
), or the proximal anterior interventricular vein (n  1),
onsistent with their idiopathic VT syndrome.
bnormal electrogram morphology: definitions. To fur-
her characterize low-amplitude signals on the epicardium,
ll low-amplitude signals were also analyzed offline to
etermine whether they: 1) were wide: electrograms
80-ms duration; 2) were split: electrograms with 2 or
ore distinct components with 20-ms isoelectric segment
etween peaks of individual components; or 3) demon-
trated late potentials (LPs): electrograms with a distinct
nset after the QRS. These electrogram characteristics were
ot considered mutually exclusive.
aseline Characteristicsf R ference Pati nts Without Structuraleart Disease Undergoing Epicardial M pping
Table 1
B seli e Characteristics
of Reference Patients Without Structural
Heart Disease Undergoing Epicardial Mapping
Patient #
Age
(yrs) Sex
LVEF
(%)
AAD at Time
of Procedure
Clinical
Arrhythmia
1 54 F 65 None NSVT
2 44 F 60 None PVC
3 50 M 60 Propafenone SMVT
4 22 F 65 None SMVT
5 37 M 55 None SMVT
6 43 F 55 Sotalol PVC
7 51 F 70 None NSVT
8 78 M 60 Sotalol PVC
AD  antiarrhythmic drugs; LVEF  left ventricular ejection fraction; NSVT  nonsustained
entricular tachycardia; PVC  premature ventricular complex; SMVT  sustained monomorphic
entricular tachycardia.
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August 25, 2009:799–808 Epicardial VT Substrate in Nonischemic Cardiomyopathyefining confluent area of low voltage. The confluent
rea of low voltage on the endocardium and epicardium was
easured with the area measurement software available on
he CARTO mapping system (Fig. 2). On the epicardium
he areas within 1.5 cm of the large epicardial coronary
essels and AV groove were excluded in the analysis of
onfluent epicardial low voltage. The coronary anatomy was
efined by coronary angiography. Importantly, the percent-
ge of abnormal electrograms that were late, wide, or split
as also determined in all confluent epicardial low-voltage
ones (including the AV groove and region of large epicar-
ial vessels). We hypothesized that the area of confluent low
mplitude in the course of coronary vessels and AV groove
ue to normal distribution of epicardial fat would tend to
isplay otherwise normal signal morphologic characteristics.
n contradistinction, the region of low voltage away from
he epicardial vessels and AV groove would tend to show
ot only low-amplitude signals but also wide, late, and split
lectrograms consistent with an abnormal arrhythmogenic
ubstrate. The confluent area of markedly low voltage (0.5
V) defined as “dense scar” was also assessed on the
ndocardium and epicardium after excluding the immediate
erivascular region as described.
picardial to endocardial distance. To more completely
efine the electroanatomic substrate, the overall epicardial to
ndocardial distance was estimated at the region of VT site of
rigin and region of the planned ablation sites with the
lectroanatomic mapping system. At least 2 opposite points in
Figure 1 Epicardial Voltage Map of a Patient With a Structural
Left anterior oblique (left) and right anterior oblique (right) views showing low-volt
left anterior descending coronary artery (LAD), right coronary artery (RCA), and atrio
values of epicardial bipolar signals by using an imaginary 1.5-cm width line (white
cine-angiography. An electrogram recorded from the AV groove low-voltage area is
associated with abnormal electrogram morphologic characteristics.ach map were measured, and the mean distance obtained was tesignated as the epicardial to endocardial distance (Fig. 3). To
nsure an accurate estimation of the real distance, catheter
ontact was corroborated by the presence of stable intracardiac
ignals as well as with evidence of pacing capture from each
oint used for the distance measurements.
lectrophysiological study and identification/ablation of
picardial VT. All patients underwent programmed stim-
lation at right ventricular and LV endocardial sites. The
timulation protocol included the delivery of up to triple
xtrastimuli from 2 ventricular sites at 2 drive cycle
engths. Standard mapping techniques were then used.
hen the VT was stable and well-tolerated, endocardial
nd/or epicardial activation mapping and entrainment map-
ing were employed (11). If the VT was not well-tolerated
r not reproducibly initiated, detailed characterization of the
rrhythmia substrate was performed, and all sites demon-
trating distinct LPs were identified. If the VT was not
ell-tolerated, pacemapping was used in and around the
bnormal substrate to define the approximate exit site of the
T circuit within the substrate or a site with a long stimulus
o QRS interval with a QRS match suggesting a more
ritical component of the VT circuit. The combination of
Ps during sinus rhythm, a long stimulus–QRS interval
uring pacemapping, and a good pacemap QRS match
uggested the likelihood of proximity to VT origin/circuit
hen a substrate-based ablation strategy was used (7,11–13).
ubstrate-based ablation from the site of the best pacemap
argeted the region of defined abnormal substrate and was
rmal Heart and Idiopathic Ventricular Tachycardia
eas (1.0 mV) corresponding to normal distribution of epicardial fat around the
cular (AV) groove. These areas were excluded to calculate the normal reference
line) along the course of the coronary vessels and the AV groove defined by
ed in the middle of the figure. Note that low voltages in the AV groove are notly No
age ar
ventri
arrow
displayypically extended to incorporate surrounding LPs (3-cm
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Epicardial VT Substrate in Nonischemic Cardiomyopathy August 25, 2009:799–808istance) within the lesion set and to transect the substrate or
xtend as a line to an anatomic boundary but no closer than 1
m to a coronary vessel or site demonstrating phrenic nerve
apture with 10- to 20-mA pacing output. Successful elimi-
ation of targeted VT was used as proof of the suspected sites’
articipation in that VT. Typical parameters for effective lesion
reation were not to exceed 45°C for an irrigated tip and 55°C
or nonirrigated tip ablation, targeting an impedance drop of
2 to 15 ohms. The acute success of ablation was defined when
ustained monomorphic VT could not be induced at the end of
he procedure.
ollow-up assessment. Ventricular tachycardia recurrence
Figure 2 Epicardial and Endocardial LV Voltage Maps From 2 P
Epicardial (A, C) and endocardial left ventricular (LV) (B, D) voltage maps from 2 p
(VT). Color range represents voltage amplitude. Purple-colored areas represent no
in red (0.5 mV). (A) Posteroanterior modified view of the epicardial voltage map
map of the same patient showing a smaller low-voltage area in the lateral wall wit
cardial LV map (D) of another patient showing scar distributed in proximity to the
recorded in the low-voltage zones (80 ms, split, and late potentials [LP]).fter hospital discharge was assessed by interrogation of the tCD (present in 21 of 22 patients), patient interview, and
CG recording obtained with the onset of any arrhythmia
ymptoms. The ICD was routinely programmed to include
monitor zone that identified rates 120 beats/min to
acilitate identification of any asymptomatic recurrences
f VT.
tatistics. All electroanatomic measurements (number of
oints, total scar area, dense scar area, area with late and/or
plit potentials) were normally distributed with the
-sample Kolmogorov-Smirnov test against a normal dis-
ribution. Continuous data are expressed as mean  SD or
ange, as appropriate. For comparing continuous variables,
ts With NICM and Epicardial VT
s with nonischemic cardiomyopathy (NICM) and epicardial ventricular tachycardia
picardium (1.0 mV) and endocardium (1.5 mV), and dense scar is depicted
g a low-voltage zone in the basal and mid-lateral LV. (B) Endocardial LV voltage
ense scar (0.5 mV). Left lateral modified view of the epicardial (C) and endo-
annulus over the basal lateral LV. In both cases abnormal electrograms wereatien
atient
rmal e
showin
h no d
mitralhe Student paired t test was used when comparing endo-
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August 25, 2009:799–808 Epicardial VT Substrate in Nonischemic Cardiomyopathyardial and epicardial characteristics among the same pa-
ients, and the Student unpaired t test was used when
omparing the characteristics of VT patients with control
ubjects with normal voltage. For comparison of noncon-
inuous variables, the McNemar test was used. A p value
0.05 was considered statistically significant.
esults
aseline characteristics of the 22 patients in the study are listed
n Table 2. All patients had been previously treated with at
east 1 antiarrhythmic drug. The mean LV ejection fraction
as 30  13%, and the mean number of prior ablation
ttempts/patient was 1.8 (range 0 to 6 attempts/patient).
A total of 73 VTs were induced in the 22 patients (mean
.3, range 1 to 7) with a mean cycle length of 392 109 ms.
ne or more epicardial VT circuits/origins could be iden-
ified in 18 patients. In the remaining 4 patients the VT
ircuit/origin was confined to the endocardium (n  3) or
as presumed to be mid-myocardial (n  1) and did not
nvolve the epicardium with the same detailed mapping/
blation techniques.
eference values for epicardial electrograms. A mean of
12  102 epicardial points was recorded/patient from the
reference patients without structural heart disease. The
ean bipolar epicardial electrogram amplitude was 3.2 
.5 mV, and 95% of all bipolar signal voltages were above
.61 mV. The mean bipolar electrogram amplitude—once
xcluding the regions of large coronary vessels and AV
roove—was 3.6  2.6 mV, and 95% of all bipolar signals
Figure 3 Epicardial to Endocardial Distance Measurements
Clipped planes in the left anterior oblique (left) and right anterior oblique views (r
endocardial (ENDO) to epicardial (EPI) distance in the lateral and the anterior wall,ere above 0.94 mV. On the basis of this analysis, we used rsignal amplitude 1.0 mV to define a normal amplitude
n the epicardium.
The mean bipolar voltage registered in the distribution of
he major coronary vessels and the AV groove was 1.4 1.8
V with 95% of the signals above 0.19 mV (Fig. 1). These
reas revealed a paucity of abnormal electrograms, with only
.2% of signals being wide and 0.9% split, and none of the
lectrograms demonstrated any LP (Table 3).
ow-voltage and dense scar areas. The mean number of
oints recorded/patient with LV cardiomyopathy was 227 
27 and 363  147 in the LV endocardial and epicardial
aps, respectively (Tables 4 and 5). Low-voltage areas (2
m2) were present in 12 of 22 LV endocardial maps (54%)
nd in 18 of 22 epicardial maps (82%) (p NS). For the 22
tudy patients the mean low-voltage area on the endocar-
ium was 30.2  43.7 cm2 versus 46.4  37.3 cm2 on the
picardium (p  0.2). “Dense scar” areas (0.5 mV) were
resent in 10 of 22 (45%) and 16 of 22 (73%) of the LV
ndocardial and epicardial maps, respectively (p  NS).
ean “dense scar” area tended to be greater on the
picardium (12.2  20.8 cm2 vs. 27.2  32.1 cm2, p 
.07). A total of 10 patients showed an abnormal epicardial
ap with a normal endocardial map, whereas only 3
atients showed abnormal endocardial with normal epicar-
ial map. Finally, in 1 patient both endocardial and epicar-
ial maps showed no confluent area of low voltage. Seven
atients had a considerably greater abnormal epicardial
ubstrate (more than 10-cm2 difference) compared with
ndocardial substrate, whereas in only 1 patient was this
hite arrows show the
ctively, assessed with electroanatomic mapping. LV  left ventricular.ight). W
respeelationship reversed. Thus, 17 (77.2%) patients in the
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Epicardial VT Substrate in Nonischemic Cardiomyopathy August 25, 2009:799–808verall group had low-voltage areas predominantly over the
picardium, whereas only 4 (18.2%) patients had low-
oltage areas predominantly over the endocardium.
All 18 patients with an epicardial VT circuit/origin
emonstrated during the electrophysiological study based
n entrainment and/or pacemapping had abnormal low-
oltage areas consistent with scar on the epicardial map. The
ean epicardial low-voltage area (1.0 mV with abnormal
lectrograms) in this subgroup of patients was significantly
arger than the endocardial low-voltage area (55.3  33.5
m2 vs. 22.9 32.4 cm2, p 0.004). Dense scar (0.5 mV)
as also more predominant in the epicardial maps of this
roup (33.3  32.5 cm2 vs. 10.5  19.6 cm2, p  0.01).
aseline Characteristics of Patients With Nonischemic CardiomyopTable 2 Baseline Characteristics of Patients With Nonischemic
Patient # Age (yrs) Sex LVEF (%) ICD AAD at
1 52 M 30 Yes Sotalol
2 70 M 30 Yes IV lidoca
3 63 M 13 Yes Amioda
4 39 M 50 Yes IV proca
5 51 M 45 Yes Metopro
6 35 M 10 Yes Sotalol
7 65 M 40 Yes Amioda
8 64 M 5 Yes Amioda
9 50 M 45 Yes Amioda
10 44 M 25 No Metopro
11 75 F 40 Yes Amioda
12 48 M 45 Yes Propafe
13 32 F 41 Yes Metopro
14 71 M 16 Yes Amioda
15 48 M 15 Yes Amioda
16 59 M 20 Yes Amioda
17 53 M 30 Yes Amioda
18 65 M 35 Yes Amioda
19 51 M 45 Yes IV lidoca
20 69 M 20 Yes Amioda
21 78 M 25 Yes Amioda
22 51 F 30 Yes IV lidoca
CD  implantable cardioverter-defibrillator; IV  intravenous; VT  ventricular tachycardia; other
istribution of Abnormal Epicardiallectrograms in Epicardial Low-Vo tage AreasTable 3 Distribution of Abnorm l EpicardialElectrograms in Epicardial Low-Voltage Areas
Epicardial
Normal Heart*
(n  8)
Epicardial
NICM†
(n  18) p Value
80 ms 2.2% 27.5% 0.001
Split 0.9% 33% 0.001
LP — 25.8% 0.001
80 ms  split 0.8% 25.7% 0.001
80 ms  LP — 10.9% 0.001
80 ms  split  LP — 10.6% 0.001
80 ms/split or LP 2.3% 49.7% 0.001
ow voltage areas1.0mV. Results reported as percent of total electrograms sampled. *In normal
eart group, low-voltage area included signals along an imaginary 1.5-cm width line through the
heoretical course of the left anterior descending artery, right coronary artery, and the atrioventric-
lar groove—no abnormal signals were recorded away from these areas. †In the 18 nonischemic
ardiomyopathy (NICM) patients, abnormal electrograms were assessed in the confluent abnormalt
ow-voltages areas away from vascular structures.
LP  late potential.nly 1 patient (6%) in this subgroup of patients had a larger
ndocardial versus epicardial low-voltage area (Fig. 4). In
ontrast (Table 6), patients in whom an epicardial VT
ircuit/origin could not be demonstrated and subsequently
ad an ablation attempt only from the endocardium (n  4)
howed abnormal low-voltage areas only over the endocar-
ium (mean area 1.5 mV, 62.5  75.5 cm2, mean
ndocardial dense scar area 15.7  25.3 cm2). All 4 patients
ad small areas of low voltage recorded from the epicardium
ither along the course of the coronary arteries or the AV
roove with rare abnormal electrograms (80-ms width in
.1%, split in 5.5%, none with LP) consistent with the
bservations also noted in the reference population.
istribution of low-voltage areas. The 12 patients with
ow-voltage areas on the endocardial map had the abnormal
ow-voltage area located over the basal LV in proximity to
he mitral and aortic valve annuli. One patient had the
ow-voltage area extending from the base to the apex. In the
ame manner, 16 of the 18 patients with epicardial low-
oltage area demonstrated the abnormality over the basal
V (Fig. 2), typically involving the corresponding lateral
V free wall (13 of 18 patients, 72%). Of the remaining
patients with epicardial low-voltage areas and epicardial
T, 1 had the abnormal low-voltage distribution over the
V mid-lateral wall and 1 over the basal area involving
he right ventricular free wall and extending well beyond
he boundaries of the left anterior descending coronary
rtery over the basal LV.
istribution of abnormal electrograms. Abnormal elec-
and VTiomyopathy and VT
of Procedure No. of Prior Procedures Epicardial VT and Substrate
1 Yes
sotalol 0 Yes
mexiletine 1 No
e 2 Yes
1 Yes
odarone 1 No
1 Yes
mexiletine 1 Yes
2 No
2 Yes
1 Yes
3 Yes
1 Yes
mexiletine 2 No
IV lidocaine 2 Yes
2 Yes
mexiletine 5 Yes
mexiletine 3 Yes
1 Yes
IV lidocaine 1 Yes
IV lidocaine 6 Yes
1 Yes
iations as in Table 1.athyCard
Time
ine 
rone 
inamid
lol
 ami
rone
rone 
rone
lol
rone
none
lol
rone 
rone 
rone
rone 
rone 
ine
rone 
rone 
inerograms were measured as a percentage of the total number
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August 25, 2009:799–808 Epicardial VT Substrate in Nonischemic Cardiomyopathyf electrograms recorded in each low-voltage region. In the
2 endocardial LV maps with confluent low-voltage areas,
he mean percentage of electrograms from these regions
ncluded 33.9% that were 80-ms wide, 33.8% split, and
1.1% demonstrating LPs. In comparison and strikingly
imilar, in the confluent low-voltage areas in the 18 epicar-
ial maps with associated epicardial VTs, 27.5% of electro-
apping Findings in Patients With Nonischemic Cardiomyopathy aTable 4 Mapping Findings in Patients With Nonischemic Cardio
Patient #
Epicardial
Involved Map
No. of Points
Mapped
Low-Voltage
Area
(cm2)
1 Yes Endo 538 52.6
Epi 548 109.3
2 Yes Endo 210 —
Epi 424 25.5
3 No Endo 156 —
Epi 238 —
4 Yes Endo 95 —
Epi 284 82.9
5 Yes Endo 348 21.9
Epi 753 31.9
6 No Endo 544 172.5
Epi 483 —
7 Yes Endo 282 46.5
Epi 329 63.7
8 Yes Endo 277 20.2
Epi 586 100.9
9 No Endo 336 40.5
Epi 331 —
10 Yes Endo 152 —
Epi 243 31.0
11 Yes Endo 205 —
Epi 475 3.7
12 Yes Endo 160 —
Epi 476 22.1
13 Yes Endo 119 —
Epi 339 50.9
14 No Endo 203 37.3
Epi 254 —
15 Yes Endo 194 41.2
Epi 160 100.0
16 Yes Endo 155 —
Epi 301 97.8
17 Yes Endo 249 124.7
Epi 197 30.5
18 Yes Endo 118 26.4
Epi 275 55.0
19 Yes Endo 181 —
Epi 393 35.0
20 Yes Endo 109 24.9
Epi 153 51.6
21 Yes Endo 89 55.4
Epi 363 88.4
22 Yes Endo 217 —
Epi 376 15.8
ow-voltage areas are considered as 1.5 mV with the endocardial (Endo) maps and 1.0 mV w
LV  left ventricular; RV  right ventricular.rams were 80-ms wide, 33% split, and 25.8% showed aPs (Table 3). Of note, an average of 49.7% of electrograms
ecorded from confluent epicardial areas of abnor-
al electrogram voltage demonstrated signals that were
ide, split, or late. No patient with confluent areas of
picardial low voltage away from major coronary vascula-
ure in the setting of NICM and epicardial VT had 20%
f the recorded electrograms demonstrating the described
ntricular Tachycardiapathy and Ventricular Tachycardia
Percent of
Surface
Percent of
Dense Scar
(<0.5 mV) Location
Endo–Epi
Distance
(mm)
17.6% 4.8% Basal-mid septum 25
28.3% 21.2% Basal-mid anterolateral
— — — 17
7.2% — Basal inferior
— — — 5
— — —
— — — 18
34.6% 16.5% Basal inferolateral
10.8% 1.4% Basal inferolateral 17
11.8% 6.7% Basal inferolateral
44.2% 14.9% Basal-mid septum 14
— — —
22.6% 12.0% Basal lateral 22
21.7% 16.6% Basal lateral
7.0% — Basal lateral 15
28.8% 18.3% Basal-mid lateral
18.5% 9.4% Basal anteroseptal 10
— — —
— — — 13
16.3% 8.7% Basal inferior
— — — 18
2.1% — RV/LV base
— — — 9
7.6% 1.9% Basal lateral
— — — 15
20.5% — Basal inferolateral
14.8% — Basal anterolateral 14
— — —
19.7% 13.1% Basal anteroseptal 21
84.5% 79.1% Basal-apex anterolateral
— — — 15
54.0% 48.2% Basal-mid inferolateral
49.8% 31.8% Basal-apex inferolateral 11
19.6% 14.4% Basal anterolateral
13.9% 6.6% Basal septum 17
19.9% 5.8% Basal-mid anterolateral
— — — 15
13.0% 7.1% Basal-mid inferolateral
13.8% 3.6% Basal-mid anterolateral 22
20.8% 4.0% Basal-apex anterolateral
29.5% 12.5% Basal inferolateral 14
39.2% 31.8% Basal inferolateral
— — — 20
7.5% 0.8% Mid-lateral
epicardial (Epi) maps.nd Vemyobnormalities.
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Epicardial VT Substrate in Nonischemic Cardiomyopathy August 25, 2009:799–808picardial to endocardial distance. The endocardial to
picardial distance in the region of ablation was measured in
ll 22 patients (Fig. 3). The mean distance obtained in the
verall group was 15.9 mm (range 8 to 25 mm). The group
f patients with a demonstrated epicardial VT circuit/origin
ad a greater epicardial to endocardial distance when
ompared with patients without epicardial VT circuit/origin
ho were ablated only from the endocardium (16.9 mm,
ange 9 to 25 mm vs. 11.5 mm, range 8 to 14 mm, p 0.02).
blation results. In the overall group, a mean of 13.5 
5.9 and 13.8  10.8 radiofrequency (RF) lesions were
pplied to the endocardium and epicardium, respectively.
he 4 patients whose VT was ablated only from the
ndocardium received a mean of 22.5  17 RF lesions.
One patient had bleeding upon pericardial puncture
resumably due to right ventricular puncture that required
rainage. No endocardial ablation had been performed. In
his patient, epicardial mapping was completed, but because
f recurrent transient hypotension without further bleeding,
he procedure was aborted before ablation could be per-
ndocardial and Epicardiallectroan tomical M pping FeaturesTable 5 E ocardial nd EpicardialElectroanatomical Mapping Features
Endocardial LV
(n  22)
Epicardial Map
(n  22)
No. of points 228  127 363  147
Total area (cm2) 246  62 366  179
Low voltage* 12 (54) 18 (82)
Dense scar (0.5 mV) 10 (45) 16 (73)
alues are mean  SD or n (%). *Low voltage considered as 1.5 mV for the endocardium and
1.0 mV for the epicardium for 2 cm2 area.
LV  left ventricle.
Figure 4 Epicardial and Endocardial Area of Confluent Low Volt
Epicardial (Epi) (red) and endocardial (Endo) (blue) area of confluent low voltage in
tachycardia (VT) identified on the basis of entrainment mapping, pacemapping, anormed, and no long-term sequelae were observed. There-
ore, we have ablation results in 21 patients.
Radiofrequency energy delivery resulted in noninducibility
f all VT in 14 of 21 patients (67%). Successful ablation in
atients ablated only from the endocardium was achieved in 2
f the 4 patients. In 1 remaining patient with unsuccessful
ndocardial ablation, a rapid “non-clinical/non-targeted” VT
as still inducible, and in the other patient, despite gradual
lowing and termination of targeted VT, the arrhythmia
emained inducible. Because no epicardial substrate was iden-
ified, we presumed this latter VT was from an intramural
ource. Patients with a demonstrated epicardial substrate and
robable epicardial involvement for the VT circuit/origin
nderwent acutely successful VT ablation in 71% of cases (12
n the 18 Patients With Epicardial VT
8 patients with epicardial ventricular
essful elimination of VT with epicardial ablation.
omparison of Demographicnd Clinical Characteristics ofatients With Endocardial Ablationly With Th se Pa ients With Epicardial VT
Table 6
Comparison of Demographic
and Clinical Characteristics of
Patients With Endocardial Ablation
Only With Those Patients With Epicardial VT
NICM Endo
Abl Only
(n  4)
NICM Epi
Abl
(n  18)
Overall
(n  22)
Male sex 4 (100) 15 (83) 19 (86)
Age 55 (35–71) 56 (32–78) 56 (32–78)
EF (%) 21  16 32  12 30  13
Clinical VT CL (ms) 445  40 379  90 396  84
ICD 4 (100) 17 (94) 21 (95)
No. of prior procedures 1.5 (1–2) 1.8 (0–6) 1.8 (0–6)
No. of induced VTs 4.7 (3–7) 3 (1–6) 3.3 (1–7)
alues are n (%), mean (range), or mean  SD.
CL  cycle length; EF  ejection fraction; ICD  implantable cardioverter-defibrillator; NICM
ndo Abl  patients with endocardial ventricular tachycardia circuit; NICM Epi Abl  patients with
picardial ventricular tachycardia circuit; VT  ventricular tachycardia.age i
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August 25, 2009:799–808 Epicardial VT Substrate in Nonischemic Cardiomyopathyf 17 patients). The remaining 5 patients who still had
nducible VT at the end of the epicardial procedure had a
oronary vessel or phrenic nerve capture within 1 cm of the
esirable ablation location so that RF energy was not delivered
t those sites. In the overall group, a nonirrigated catheter was
sed in the first 6 patients (27%), both nonirrigated and
rrigated catheters in 6 patients and only an irrigated catheter in
he last 10 patients studied. The transition to irrigated ablation
ccurred because of difficulties achieving adequate (20 W)
picardial power delivery in 2 of the first 6 patients that we
elieve might also have contributed to the lack of acute efficacy.
A minimum of 1 year follow-up was obtained for all
urviving patients who underwent ablation (range 12 to 33
onths, mean 18  7 months). Fifteen of the 21 patients
71%) had no VT during follow-up. Fourteen of these 15
atients underwent epicardial ablation.
During the first year of follow-up 2 patients underwent
ardiac transplant, and 4 patients died during follow-up. No
atient died suddenly. Two patients died from progressive
eart failure, and 2 patients died from noncardiac causes.
ne additional patient underwent transplant at 16 months.
f these 7 patients with transplant or death, 4 had VT
efore death or transplant.
Of the 14 patients who survived 1 year without trans-
lant, 12 (86%) had no VT during follow-up. One patient
ad 2 isolated VT recurrences, and 1 additional patient had
ecurrent VT requiring repeat ablation and antiarrhythmic
rug changes. Antiarrhythmic medications were not rou-
inely eliminated after ablation. Of the 14 surviving patients,
were taking amiodarone at a dose 200 mg/day, and 3
atients were taking sotalol.
iscussion
his is the first study to establish criteria for normal bipolar
picardial electrograms and then to use this reference data to
haracterize the epicardial electroanatomical substrate in a
arge series of patients with NICM. Our results show that
atients with NICM and VT suspected to originate from
he epicardium, either because the 12-lead ECG was
uggestive or because previous unsuccessful endocardial
blation had been attempted, are likely to have a large
picardial substrate represented by confluent low-voltage
reas with abnormal electrogram signals consistent with scar
n up to 82% of patients. Moreover, in patients with
onfirmed epicardial VT on the basis of entrainment and/or
acemapping, the epicardial scar area was larger than the
ndocardial LV scar area. Finally, these epicardial low-
oltage areas have a typical distribution similar to that
reviously described for endocardial LV maps, usually lo-
ated in basal lateral areas of the LV (1,2).
Previous studies had reported the endocardial and/or
picardial features in patients with ischemic dilated cardio-
yopathy and in a smaller number of patients with NICM
1–4,13–15). Soejima et al. (3) described the epicardial
lectroanatomical characteristics of 7 patients with NICM Not amenable to endocardial VT ablation. All of these
atients had low-amplitude regions in the epicardium con-
istent with scar. The average epicardial scar area was
7.5  10.4 cm2, which was only modestly lower than the
picardial mean low-voltage area in the 18 patients included
n our study who demonstrated an epicardial substrate and
T origin (55.3  33.5 cm2).
Low-voltage areas have been described in the epicardium
s a result of the normal distribution of fat tissue (9,10). The
resence of epicardial fat might also represent an important
bstacle to the effectiveness of VT ablation. To avoid a
isclassification of low-voltage areas due to epicardial fat or
ajor coronary vasculature as abnormal, we established a
eference standard in 8 patients without structural heart
isease and idiopathic VT. Our results show that normal
picardial electrograms demonstrate bipolar signal ampli-
ude that is typically above 0.94 mV; whereas signal ampli-
ude associated with fat and/or large vessel coronary anat-
my might demonstrate significantly lower amplitude.
mportantly, despite the lower amplitude, the presence of
abnormal” electrogram signal characteristics in these areas
s indeed unusual (2.3%). In contrast, within “true low-
oltage areas” in NICM and epicardial VT, nearly 50% of
lectrograms are typically markedly abnormal. In fact, the
inimum percentage of abnormal electrograms in the
ow-voltage area associated with an epicardial VT was 20%.
hus, the decision about whether a low-voltage epicardial
rea is really “scar” and represents an appropriate substrate
or VT should rely on location and extent of the confluent
oltage abnormality as well as on the presence of abnormal
lectrogram signals (80 ms, split, or LP). The presence of
Ps seems to be most specific for identifying the epicardial
T substrate in that they were never observed in the
eference group (Table 3).
Another important finding of the study is the fact that
atients with an epicardial VT circuit/origin are more likely
o have a greater epicardial to endocardial distance deter-
ined by electroanatomic mapping than patients who can
e successfully ablated from the endocardium. In the pres-
nce of a greater distance, ablation lesions delivered from
he endocardial surface might not reach the deeper intra-
ural or epicardial aspect of the circuit even with irrigated
blation.
Finally, long-term elimination of VT was achieved in the
ajority of patients with aggressive epicardial ablation. This
upports data from other smaller series and emphasizes the
mportance of this approach in the management of VT in
his setting (3). Despite the VT control, a significant
umber of patients ultimately required transplant, and
verall mortality remained high in this patient population.
tudy limitations. The study population with NICM was
elected in that the patients had either failed previous
ndocardial ablation attempts or had 12-lead ECG suggest-
ng an epicardial VT origin. Thus, these findings might not
e extrapolated to the entire population of patients with
ICM and VT. Importantly, the group of 4 patients in
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Epicardial VT Substrate in Nonischemic Cardiomyopathy August 25, 2009:799–808hich the detailed mapping and ablation outcome demon-
trated that the epicardium was not part of the VT circuit is
mall; thus, the hypothesis that the location of the VT
ircuit could be surmised by the location (endocardial vs.
picardial) of the largest extent of the abnormal voltage and
lectrogram area is suggested but not proven by these data.
Although special attention was given to obtain accurate
easurements of the epicardial to endocardial distance, the
se of the CARTO system for this purpose has not been yet
alidated with established imaging techniques in this set-
ing. Finally, anatomo-pathological correlation of the low-
oltage areas with associated marked electrogram abnormal-
ties is not available in our study. Nevertheless, the absence
f such electrogram abnormalities in low-voltage regions
ordering major coronary vessels is compelling. Our obser-
ations should serve as a useful guide for distinguishing
at/coronary vasculature from abnormal anatomic areas that
erve as the substrate for VT. Ongoing studies in explanted
earts should confirm these observations.
onclusions
n patients with NICM and VT unamenable to endocardial
blation or with ECG criteria suggesting an epicardial origin,
he presence of an epicardial substrate represented by sizable
onfluent abnormal low-voltage areas (1.0 mV) located
redominantly over the basal lateral LV is common. At least
0% of signals in the low-voltage area should be wide (80
s), split, and/or late to definitively identify an epicardial scar
hat might serve as a substrate for VT. An ablation strategy
hat targets these epicardial VT and the VT substrate can result
n intermediate-term arrhythmia control in most patients.
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